Moreover, both receptive vocabulary and speech production in the youngest group were comparable with a control group of normal-hearing children “and significantly better than growth rates achieved by children implanted after six months.”
The complications that occurred during the study were all deemed minor. For example, two children in the study (aged 13 and 24 months) experienced transitory bronchospasm and hypotension as a result of anesthesia. In both cases, the reactions resolved with medical treatment.
For Dr. Colletti, the results confirmed that infants younger than six months of age can be safely and effectively implanted and given a chance to achieve “their full [hearing and developmental] potential, offsetting the need to learn at a faster than normal rate to attain age-appropriate norms.”